Curigliano, Giuseppe’s recent research focuses on establishing pathological detection standards, exploring ADC drug applications, investigating genomic characteristics, and assessing prognostic implications related to HER2-low expression breast cancer [22–25]. The gene discussed is ERBB2; the disease is breast cancer.